{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:17:51Z","timestamp":1793751471736,"version":"4.6.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374102"],"award-info":[{"award-number":["82374102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY23H040001"],"award-info":[{"award-number":["LY23H040001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.phymed.2024.155799","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:56:38Z","timestamp":1717462598000},"page":"155799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Geniposide dosage and administration time: Balancing therapeutic benefits and adverse reactions in liver disease treatment"],"prefix":"10.1016","volume":"132","author":[{"given":"Jiannan","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.155799_bib0001","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.phymed.2024.155799_bib0002","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1039\/D0FO00487A","article-title":"Commercial whey products promote intestinal barrier function with glycomacropeptide enhanced activity in downregulating bacterial endotoxin lipopolysaccharides (LPS)-induced inflammation in vitro","volume":"11","author":"Arbizu","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.phymed.2024.155799_bib0003","series-title":"Guide For the Care and Use of Laboratory Animals","author":"Care","year":"2011"},{"key":"10.1016\/j.phymed.2024.155799_bib0004","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","article-title":"Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis","volume":"76","author":"Ciccia","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phymed.2024.155799_bib0005","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2016.08.001","article-title":"Bile acid analog intercepts liver fibrosis","volume":"166","author":"De Magalhaes","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.155799_bib0006","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2001.25503","article-title":"The orphan nuclear receptor, shp, mediates bile acid-induced inhibition of the rat bile acid transporter, ntcp","volume":"121","author":"Denson","year":"2001","journal-title":"Gastroenterology."},{"key":"10.1016\/j.phymed.2024.155799_bib0007","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jhep.2013.01.038","article-title":"Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function","volume":"58","author":"Du Plessis","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155799_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104945","article-title":"Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: more friend than foe","volume":"159","author":"Fan","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2024.155799_bib0009","doi-asserted-by":"crossref","first-page":"29745","DOI":"10.1074\/jbc.273.45.29745","article-title":"The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton","volume":"273","author":"Fanning","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2024.155799_bib0011","first-page":"1499","article-title":"Geniposide attenuates cadmium\u2011induced oxidative stress injury via Nrf2 signaling in osteoblasts","volume":"20","author":"He","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phymed.2024.155799_bib0012","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2036.2012.05221.x","article-title":"Mesenteric phlebosclerosis associated with long-term oral intake of geniposide, an ingredient of herbal medicine","volume":"36","author":"Hiramatsu","year":"2012","journal-title":"Aliment. Pharm. Ther."},{"key":"10.1016\/j.phymed.2024.155799_bib0013","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phymed.2024.155799_bib0014","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2024.155799_bib0015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2004.06.033","article-title":"Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis","volume":"41","author":"Inao","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155799_bib0016","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phymed.2024.155799_bib0017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molmet.2018.01.005","article-title":"Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR","volume":"9","author":"Jadhav","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.phymed.2024.155799_bib0018","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2024.155799_bib0019","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ccell.2016.10.007","article-title":"Circadian homeostasis of liver metabolism suppresses hepatocarcinogenesis","volume":"30","author":"Kettner","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2024.155799_bib0020","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.bcp.2005.07.025","article-title":"Genipin-induced apoptosis in hepatoma cells is mediated by reactive oxygen species\/c-Jun NH2-terminal kinase-dependent activation of mitochondrial pathway","volume":"70","author":"Kim","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155799_bib0021","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/hep.29199","article-title":"Hepatic FXR\/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2024.155799_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110077","volume":"118","author":"Kimura","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2024.155799_bib0023","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jhep.2020.07.028","article-title":"Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis","volume":"74","author":"Kjaergaard","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155799_bib0024","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.gastro.2003.06.005","article-title":"Enterohepatic bile salt transporters in normal physiology and liver disease","volume":"126","author":"Kullak-Ublick","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2024.155799_bib0025","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.tibs.2006.08.002","article-title":"FXR, a multipurpose nuclear receptor","volume":"31","author":"Lee","year":"2006","journal-title":"Trends. Biochem. Sci."},{"key":"10.1016\/j.phymed.2024.155799_bib0026","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phymed.2024.155799_bib0027","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3748\/wjg.v23.i7.1125","article-title":"Therapeutic mechanism of Yin-Chen-Hao decoction in hepatic diseases","volume":"23","author":"Li","year":"2017","journal-title":"World J. Gastroentero"},{"key":"10.1016\/j.phymed.2024.155799_bib0028","article-title":"Antioxidative property and molecular mechanisms underlying geniposide-mediated therapeutic effects in diabetes mellitus and cardiovascular disease","volume":"2019","author":"Li","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.phymed.2024.155799_bib0029","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/s41418-021-00755-6","article-title":"GSDME-mediated pyroptosis promotes inflammation and fibrosis in obstructive nephropathy","volume":"28","author":"Li","year":"2021","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.phymed.2024.155799_bib0030","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","article-title":"Primary biliary cholangitis","volume":"396","author":"Lleo","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.phymed.2024.155799_bib0031","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.155799_bib0032","first-page":"222","article-title":"Hepatic injury in nonalcoholic steatohepatitis contributes to altered intestinal permeability","volume":"1","author":"Luther","year":"2015","journal-title":"Cell Mol. Gastroenter."},{"key":"10.1016\/j.phymed.2024.155799_bib0033","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbadis.2017.10.003","article-title":"Farnesoid x receptor: a \"homeostat\" for hepatic nutrient metabolism","volume":"1864","author":"Massafra","year":"2018","journal-title":"BBA-Mol. Basis Dis."},{"key":"10.1016\/j.phymed.2024.155799_bib0034","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrgastro.2013.146","article-title":"The Gordian knot of dysbiosis, obesity and NAFLD","volume":"10","author":"Mehal","year":"2013","journal-title":"Nat. Rev. Gastro. Hepat."},{"key":"10.1016\/j.phymed.2024.155799_bib0035","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2024.155799_bib0036","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrgastro.2016.169","article-title":"The intestinal epithelial barrier: a therapeutic target?","volume":"14","author":"Odenwald","year":"2017","journal-title":"Nat. Rev. Gastro Hepat."},{"key":"10.1016\/j.phymed.2024.155799_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155111","article-title":"Xie Zhuo Tiao Zhi formula modulates intestinal microbiota and liver purine metabolism to suppress hepatic steatosis and pyroptosis in NAFLD therapy","volume":"121","author":"Qiu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2024.155799_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113658","article-title":"Metabolomics analysis delineates the therapeutic effects of Huangqi decoction and astragalosides on alpha-naphthylisothiocyanate (ANIT) -induced cholestasis in rats","volume":"268","author":"Qiu","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2024.155799_bib0040","first-page":"851","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol."},{"key":"10.1016\/j.phymed.2024.155799_bib0041","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41591-022-02200-8","article-title":"Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a\/b trial","volume":"29","author":"Sanyal","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2024.155799_bib0042","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41418-018-0122-7","article-title":"Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosis","volume":"26","author":"Sarhan","year":"2019","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.phymed.2024.155799_bib0043","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.1111\/jcmm.15139","article-title":"Geniposide alleviates non-alcohol fatty liver disease via regulating Nrf2\/AMPK\/mTOR signalling pathways","volume":"24","author":"Shen","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.phymed.2024.155799_bib0044","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s00535-016-1218-9","article-title":"Involvement of herbal medicine as a cause of mesenteric phlebosclerosis: results from a large-scale nationwide survey","volume":"52","author":"Shimizu","year":"2017","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.phymed.2024.155799_bib0045","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hep.20003","article-title":"Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver","volume":"39","author":"Shoda","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2024.155799_bib0046","doi-asserted-by":"crossref","first-page":"re3","DOI":"10.1126\/scisignal.272re3","article-title":"CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior","volume":"2","author":"Silverstein","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.phymed.2024.155799_bib0047","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","article-title":"The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013","volume":"388","author":"Stanaway","year":"2016","journal-title":"LANCET."},{"key":"10.1016\/j.phymed.2024.155799_bib0048","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ecco-jcc\/jjab134","article-title":"An IRF1-dependent pathway of TNFalpha-induced shedding in intestinal epithelial cells","volume":"16","author":"Tan","year":"2022","journal-title":"J. Crohns. Colitis."},{"key":"10.1016\/j.phymed.2024.155799_bib0049","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jep.2017.11.008","article-title":"Oral chronic toxicity study of geniposide in rats","volume":"213","author":"Tian","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2024.155799_bib0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jep.2016.12.022","article-title":"Geniposide attenuates ANIT-induced cholestasis through regulation of transporters and enzymes involved in bile acids homeostasis in rats","volume":"196","author":"Wang","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2024.155799_bib0051","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41586-023-05857-4","article-title":"Clonal haematopoiesis and risk of chronic liver disease","volume":"616","author":"Wong","year":"2023","journal-title":"Nature."},{"key":"10.1016\/j.phymed.2024.155799_bib0052","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2017.07.045","article-title":"Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs","volume":"262","author":"Wu","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.phymed.2024.155799_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.05.010","article-title":"Geniposide protected hepatocytes from acetaminophen hepatotoxicity by down-regulating CYP 2E1 expression and inhibiting TLR 4\/NF-kappaB signaling pathway","volume":"74","author":"Yang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phymed.2024.155799_bib0055","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1248\/bpb.27.1580","article-title":"Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora","volume":"27","author":"Yim","year":"2004","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phymed.2024.155799_bib0056","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/hepr.12299","article-title":"Current scenario for the hepatoprotective effects of inchinkoto, a traditional herbal medicine, and its clinical application in liver surgery: a review","volume":"44","author":"Yokoyama","year":"2014","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.phymed.2024.155799_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117061","article-title":"Bidirectional effects of geniposide in liver injury: preclinical evidence construction based on meta-analysis","volume":"319","author":"Zeng","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2024.155799_bib0058","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1021\/acs.jafc.2c08175","article-title":"Glutathione s-transferases mediate in vitro and in vivo inactivation of genipin: implications for an underlying detoxification mechanism","volume":"71","author":"Zhao","year":"2023","journal-title":"J. Agr. Food Chem."},{"key":"10.1016\/j.phymed.2024.155799_bib0059","doi-asserted-by":"crossref","first-page":"47006","DOI":"10.1289\/EHP11600","article-title":"Assessment of nonalcoholic fatty liver disease symptoms and gut-liver axis status in zebrafish after exposure to polystyrene microplastics and oxytetracycline, alone and in combination","volume":"131","author":"Zhou","year":"2023","journal-title":"Environ. Health Persp."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324004574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324004574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T15:14:55Z","timestamp":1723648495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324004574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":56,"alternative-id":["S0944711324004574"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155799","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geniposide dosage and administration time: Balancing therapeutic benefits and adverse reactions in liver disease treatment","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155799"}}